Cytosorbents CTSO
NASDAQ CTSO
$4.00 +0.00 (+0.00%)
As of: Sep 30, 2026 · 3:56 PM EDT

Cytosorbents (CTSO) Restructuring Costs (2026)

Updated

Cytosorbents (CTSO) recorded Restructuring Costs of $300,000 in Q2 2026.

Analysis

Cytosorbents (CTSO) Restructuring Costs (2026) Analysis & Trends

For FY2025, Cytosorbents reported Restructuring Costs of $510,000.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 251.30 Bn 230.45 Bn 4.88 Bn
2 Abbott Laboratories 174.70 Bn 145.78 Bn 7.27 Bn
3 Danaher 158.94 Bn 142.76 Bn 3.61 Bn
4 Intuitive Surgical 145.87 Bn 125.42 Bn 1.96 Bn
5 Medtronic 111.49 Bn 77.36 Bn 6.34 Bn
6 Stryker 106.96 Bn 93.08 Bn 4.50 Bn
7 Boston Scientific 63.62 Bn 58.63 Bn 3.85 Bn
8 Edwards Lifesciences 50.80 Bn 34.92 Bn 1.35 Bn
9 Becton Dickinson 49.59 Bn 46.74 Bn 2.32 Bn
10 Cytosorbents 12.57 Mn -10.44 Mn 7.05 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 300,000.00
API Access

Cytosorbents Restructuring Costs API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=restructuring-costs&ticker=CTSO&period=max&api_key=YOUR_API_KEY